Clinical Trials Sponsored by UC Global Health Institute

Total 219 results

Barcelona Institute for Global Health

Completed

Pregnant Women for Malaria Surveillance (MiPMon)

P. Falciparum
Barcelona Institute for Global Health

Completed

Maternal Diet, Body Mass Index Trajectories and Cardiometabolic Risk in Early Childhood

Growth | Childhood Obesity | Cardiometabolic Risk
Barcelona Institute for Global Health

Completed

Fatty Acids and Attention Deficit and Hyperactivity Disorder Symptoms

Attention Deficit Hyperactivity Disorder | Child Behavior Problem | Fatty Acid Deficiency
Barcelona Institute for Global Health

Completed

PHENOTYPE. Therapeutic Study in Barcelona

Poor Mental Health | Natural Outdoor Environments
Barcelona Institute for Global Health
UNITAID

Active, not recruiting

Broad One Health Endectocide-based Malaria Intervention in Africa (BOHEMIA) (BOHEMIA)

Malaria

Mozambique, Kenya
Jhpiego
Barcelona Institute for Global Health

Completed

TIPTOP Sulfadoxine-pyrimethamine (SP) Drug Resistance Study (TIPTOP-DRS)

Malaria in Pregnancy

Congo, The Democratic Republic of the, Madagascar, Mozambique, Nigeria
Jhpiego
Barcelona Institute for Global Health

Completed

Evaluating the Effects of Community Delivery of Malaria Intermittent Preventive Treatment on Pregnant Women and Babies (TIPTOP)

Malaria in Pregnancy

Congo, The Democratic Republic of the, Madagascar, Mozambique, Nigeria
Barcelona Institute for Global Health
Carlos III Health Institute

Completed

Walnuts, Long-Chain Polyunsaturated Fatty Acids and Adolescent Brain Development (WALNUTs)

Neurobehavioral Manifestations | Vitamin/Nutritional Deficiency

Spain
Karolinska Institutet
The George Institute for Global Health, India

Not yet recruiting

ATLS vs Standard Care Trial

Wounds and Injuries
The George Institute for Global Health, Australia

Completed

Days Alive and Out of Hospital for Patients With Sepsis

Sepsis | Septic Shock

Australia
GSK Vaccines Institute For Global Health S.r.l.

Completed

A Phase 1, Dose Escalation Study, to Evaluate a New Shigella Sonnei Vaccine in Healthy Adults.

Shigellosis

France
The George Institute for Global Health, China

Completed

Activating Media for Salt Reduction

Hypertensive Disease

China
The George Institute for Global Health, China

Completed

Rehabilitation for Disabled Stroke Patients in Rural China (RECOVER)

Stroke

China
The George Institute for Global Health, China

Completed

China Rural Health Initiative Follow up Study (CRHIFU)

Cardiovascular Disease

China
MGH Institute of Health Professions
LSVT Global

Completed

Incorporating Strategy Training Into Naming Treatment in Aphasia

Aphasia

United States
The George Institute for Global Health, China

Completed

Clinical Pathways for the Management of Acute Coronary Syndromes - Phase 3,CPACS-3 (CPACS-3)

Acute Coronary Syndromes

China
GSK Vaccines Institute For Global Health S.r.l.

Completed

Evaluate a New Shigella Sonnei Vaccine Administered Either by Intradermal, Intranasal or Intramuscular Route in Healthy Adults

Shigellosis

United Kingdom
The George Institute for Global Health, Australia

Completed

The Fluid Translation of Research Into Practice Study (Fluid-TRIPS)

Critical Care, Fluid Resuscitation

Australia
University of California, Davis
UC Davis Foods for Health Institute; Mengniu Dairy

Active, not recruiting

An Examination of Infants' Microbiome, Nutrition, and Development Study. (IMiND)

Microbial Colonization | Infant Development

United States
University of California, San Francisco
Fogarty International Center of the National Institute of Health; Office of... and other collaborators

Completed

Evaluating the Impact of the National Health Insurance Scheme of Ghana on Surgical Care

General Surgery, Costs and Cost Analysis

Ghana
Beijing Anzhen Hospital
The George Institute for Global Health, Australia; The George Institute for... and other collaborators

Recruiting

Cardiovascular Risk Reduction in Atrial Fibrillation Trial (CRAFT)

Hypertension | Atrial Fibrillation

China
Beijing Anzhen Hospital
The George Institute for Global Health, Australia; The George Institute for... and other collaborators

Recruiting

Comparison Between Upgraded '2C3L' vs. PVI Approach for Catheter Ablation of Persistent Atrial Fibrillation (PROMPT-AF)

Persistent Atrial Fibrillation | Catheter Ablation

China
The George Institute for Global Health, China
Changhai Hospital

Recruiting

Large Artery Occlusion Treated in Extended Time With Mechanical Thrombectomy Trial (LATE-MT)

Acute Ischemic Stroke

China
The George Institute for Global Health, China
Changhai Hospital

Terminated

Second Enhanced Control of Hypertension and Thrombectomy Stroke Study (ENCHANTED2) (ENCHANTED2)

Acute Ischemic Stroke

China
Universidad Peruana Cayetano Heredia
Barcelona Institute for Global Health

Completed

Randomized Phase IIA Clinical Trial to Evaluate the Efficacy of Ivermectin to Obtain Negative PCR Results in Patients With Early Phase COVID-19 (SAINT-PERU)

Coronavirus Infection | Covid19 | SARS-CoV Infection

Peru
Duke University
The George Institute for Global Health, China

Completed

Weight Loss Among Adults in Beijing, China

Hypertension | Obesity

China
Lisbon Institute of Global Mental Health - LIGMH
Columbia University

Recruiting

Critical Time Intervention-Peer Support (CTI-PS)

Psychotic Disorders | Schizophrenia | Bipolar Disorder | Schizo Affective Disorder

Portugal
Hospital Universitari Vall d'Hebron Research Institute
Barcelona Institute for Global Health

Completed

Noninvasive Respiratory Support in COVID-19 (CATCOVID-AIR) (CATCOVID-AIR)

Covid19 | Corona Virus Infection | Acute Respiratory Failure

Spain
Craig Anderson
Johns Hopkins University; Genentech, Inc.; The George Institute for Global Health...

Recruiting

Optimal Post Tpa-Iv Monitoring in Ischemic Stroke

Acute Ischemic Stroke Patients Receiving Reperfusion Therapy

Australia, United Kingdom, United States, Chile, China, Malaysia, Mexico
WCCT Global
National Institutes of Health (NIH); Stanford University

Completed

Single Ascending Dose Challenge Study to Determine Safety and Reactogenicity of an Influenza Challenge Virus

Influenza
The George Institute for Global Health, China
National Heart, Lung, and Blood Institute (NHLBI)

Completed

High Cardiovascular Risk Management and Salt Reduction in Rural Villages in China

Cardiovascular Disease

China
Unity Health Toronto
Canadian Institutes of Health Research (CIHR); The George Institute for Global...

Completed

Strategies for the Management of Atrial Fibrillation in patiEnts Receiving Dialysis (SAFE-D)

Atrial Fibrillation | End Stage Renal Failure on Dialysis

Canada, Australia
University of Sydney
The George Institute for Global Health, India

Terminated

Controlled Trial of Angiotensin Receptor Blocker (ARB) & Chemokine Receptor Type 2 (CCR2) Antagonist for the Treatment of COVID-19 (CLARITY 2)

COVID-19 | SARS-CoV2 Infection

India
University of Calgary
The George Institute for Global Health, Australia

Not yet recruiting

ACT-GLOBAL THROMBOLYSIS (ACT-WHEN-001) Domain Within the ACT-GLOBAL Adaptive Platform Trial (ACT-WHEN)

Acute Ischemic Stroke AIS | Stroke, Acute, Stroke Ischemic | Stroke Acute

Canada, Australia
The George Institute for Global Health, China
Ningxia Medical University

Completed

NUTS for the Prevention of Cardiovascular Disease in Chinese Adults (NUTS)

Cardiovascular Diseases | Dyslipidemias

China
The George Institute for Global Health, China
Chinese Diabetes Society

Completed

Observational Registry for Basal Insulin Treatment Study (ORBIT)

Diabetes

China
The George Institute for Global Health, China
National Health and Medical Research Council, Australia; Global Alliance for...

Completed

SMARTHealth Diabetes in China Using Lay Family Health Promoters

Hypertension | Diabetes Mellitus, Type 2 | Dyslipidemias

China
Janssen Research & Development, LLC
The George Institute for Global Health, Australia

Completed

A Study of the Effects of Canagliflozin (JNJ-28431754) on Renal Endpoints in Adult Participants With Type 2 Diabetes Mellitus (CANVAS-R)

Diabetes Mellitus, Type 2 | Albuminuria

Australia, France, Italy, Poland, Ukraine, United Kingdom, United States, China, Belgium, Germany, Taiwan, Spain, Argentina, Mexico, Malaysia, Canada, Netherlands, Korea, Republic of, New Zealand, Brazil, Russian Federation, Puerto... and more
Omico
Hoffmann-La Roche; The George Institute for Global Health, Australia

Recruiting

Tiragolumab and Atezolizumab in Advanced Pan-cancer Patients (MoST-TAP)

Solid Tumor, Adult

Australia
Janssen Research & Development, LLC
The George Institute for Global Health, Australia

Completed

Evaluation of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Participants With Diabetic Nephropathy (CREDENCE)

Diabetes Mellitus, Type 2 | Diabetic Nephropathy

United States, Canada, France, Germany, Poland, Ukraine, United Kingdom, China, Taiwan, Spain, Argentina, Colombia, Mexico, Bulgaria, India, Malaysia, Romania, Serbia, South Africa, Japan, Australia, Korea, Republic of, Chile, New Zealand and more
Janssen Research & Development, LLC
The George Institute for Global Health, Australia

Completed

CANVAS - CANagliflozin cardioVascular Assessment Study (CANVAS)

Cardiovascular Diseases | Diabetes Mellitus, Type 2 | Risk Factors

United States, Australia, Poland, Ukraine, United Kingdom, Belgium, Germany, France, Spain, Argentina, Colombia, Israel, Mexico, India, Canada, Netherlands, Sweden, Malaysia, New Zealand, Estonia, Russian Federation, Hungary, Norway, ... and more
Vladimíra Dostálová
Barcelona Institute for Global Health

Recruiting

Testing a Nature-based Socila Intevention on Loneliness: the RECETAS-PRG Trial

Loneliness

Czechia
The George Institute for Global Health, China
Peking University People's Hospital

Completed

Telmisartan and Hydrochlorothiazide Antihypertensive Treatment Study in High Sodium Intake Population

Hypertension

China
African Population and Health Research Center
Amsterdam Institute for Global Health and Development; PharmAccess

Unknown

Enhancing Universal Health Coverage and Maternal, Newborn and Child Health in Kenya Through Digital Innovations (UHC)

Universal Health Coverage
University of Dschang
Barcelona Institute for Global Health; University of Yaounde 1

Recruiting

Plasmodium Vivax Among Duffy Negative Population in Cameroon. (VIBRANT)

Malaria | Malaria, Vivax | Malaria,Falciparum

Cameroon
Centro de Investigação em Saúde de Manhiça
Barcelona Institute for Global Health

Completed

Mass Drug Administrations of DHA-PQP to Accelerate Towards Malaria Elimination in Magude District, Southern Mozambique (MDAM)

Malaria
The George Institute for Global Health, China
National Institute of Mental Health (NIMH); Peking University Sixth Hospital

Completed

Integrating Depression Care in Acute Coronary Syndromes Care in China (I-Care)

Depression | Acute Coronary Syndromes

China
Texas A&M University
Driscoll Children's Hospital; Global Institute for Hispanic Health

Recruiting

Impact of a Mobile App on Pregnant Women's Prenatal Genetic Testing Decision-making

Pregnant Women | Mobile Applications | Prenatal Care | Genetic Testing

United States
Global Health Drug Discovery Institute
CMAX Clinical Research Pty Limited; Avance Clinical

Completed

SAD Study of APR002 Investigating the Safety/Tolerability, Pharmacokinetics/Pharmacodynamics in Healthy Subjects

COVID-19

Australia
Clinica Universidad de Navarra, Universidad de...
Barcelona Institute for Global Health

Completed

Sars-CoV-2/COVID-19 Ivermectin Navarra-ISGlobal Trial (SAINT)

Coronavirus Infection | Covid-19 | SARS-CoV-2 Infection

Spain

Clinical Trials Sponsored by UC Global Health Institute

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mali

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations